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ABSTRACT
Syphilis has the potential to result in serious, irreversible morbidity and mortality during
pregnancy and has increased in incidence across the United States. While syphilis is
a common disease and a known but rare cause of membranous nephropathy, it can
complicate the clinical picture and obscure accurate diagnosis of women presenting
with proteinuria during pregnancy. We report a case of proteinuria with syphilis in the
second trimester of pregnancy as an educational review.
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INTRODUCTION

CASE PRESENTATION

Syphilis has increased in incidence across the
United States over the past decade despite effective
identification and treatment.1 Untreated syphilis
can result in serious, irreversible morbidity during
pregnancy via vertical transmission to the fetus
and maternal sequelae seen in the secondary and
tertiary stages of the disease.2 There has also been
an increase in congenital syphilis, with 8.4 cases per
100,000 live births during 2008–2012 and 11.6 cases
per 100,000 live births in 2014, which is the highest
rate reported since 2001.3,4 While pregnancy can
present with proteinuria from normal or abnormal
physiologic changes during pregnancy, syphilis is a
common disease and a known cause of membranous
glomerulonephritis; however, the manifestation
is rare during pregnancy and not reported in the
literature. We report a case of proteinuria with
syphilis in the second trimester of pregnancy as a
mini-review, as we believe syphilitic membranous
glomerulonephritis to be an important addition
to the differential diagnosis of proteinuria during
pregnancy. The aim of this mini-review is for the
education of physicians, residents, and students.

A 32-year-old female at 21 weeks gestation presented
to the emergency department after being physically
and sexually assaulted by her significant other.
Physical exam demonstrated bruising and tenderness
to the patient’s left periorbital and abdominal areas,
and vaginal and anal bleeding. The physical exam was
otherwise unremarkable, and there were no physical
exam findings indicative of syphilitic infection. The
patient was admitted for inpatient management and
continued maternal and fetal evaluation.
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The patient’s medical history was significant for a
reactive rapid plasma reagin (RPR) of 1:128 three
months prior to her current hospital admission,
at which time a positive serum pregnancy test
was documented. Treatment was arranged at a
public health clinic, but the patient did not attend
the appointment or receive antibiotic treatment
elsewhere. A repeat RPR of 1:132 was present on
hospital admission, and syphilis was confirmed
with a fluorescent treponemal antibody screening
(FTAbS) test. Due to physician concern for
neurosyphilis, a lumbar puncture was performed
and showed no signs of spirochetal infection in
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the cerebrospinal fluid. A 24-hour urine specimen
showed subnephrotic proteinuria of 1.5 grams with
a urinalysis consistent with an ongoing lower urinary
tract infection (Table 1).

TABLE 1. (UA dipstick and UA micro showing with
unrevealing findings except for variant levels of WBCs and
leukocyte esterase consistent with urinary tract infection)

FIGURE 1. 24-hour urine protein collection measured in
mg/24hr. Penicillin G Benzathine was given November 10.
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Bloodwork was significant for hypoalbuminemia (1.8
gm/dl), elevated creatinine concentration (1.12 mg/
dl), low protein (6.3 gm/dl), and E. coli bacteremia.
No lipid panel was performed as part of this patient’s
workup. Pertinent negative findings included normal
C3 and C4 levels (146 and 20 mg/dl, respectively),
a negative hepatitis panel, and a negative fourthgeneration Human Immunodeficiency Virus (HIV)
test. Ultrasound of the kidneys revealed an 18mm
echogenic mass on the left kidney, interpreted to
be an angiomyolipoma. There was no evidence
of hydronephrosis or urinary obstruction. A urine
culture subsequently demonstrated chlamydial
infection without gonorrhea. Antibiotic treatment
for chlamydia and E. coli bacteremia was
azithromycin and ceftriaxone. The patient refused
thromboprophylaxis with low molecular weight
heparin. The nephrology service was consulted for
the management of acute kidney injury (AKI) while
the patient was admitted. The lack of physical exam
findings for syphilitic lesions, confirmatory FTAbS,
and laboratory values, including the negative HIV test
and hepatitis panel, weighted the diagnosis toward
membranous nephropathy due to secondary syphilis.
However, this diagnosis was not confirmed with renal
biopsy.
The patient was started on a weekly course of
intramuscular penicillin G benzathine for 3 weeks.
RPR trended downward immediately following
initiation of penicillin treatment, and a repeat 24hour urine collection 7 days later showed a sharp
downward trending urinary protein. Proteinuria and
serum albumin were tracked on follow-up visits over
the next 4 months, as shown in Figures 1 and 2.

FIGURE 2. Serum albumin measured in mg/dl
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The patient left the hospital against medical advice
and returned 8 days later for domestic abuse.
Urine collection still showed proteinuria of 264
mg/24hr, lower than her previous measurement. She
received her final IM penicillin shot during this stay,
completing the course of her treatment.
At a follow-up appointment 5 weeks after the initial
diagnosis, an RPR titer of 1:64 was documented.
The patient continued to be followed in the highrisk obstetric clinic until the delivery of her child at
36 weeks gestation. Her RPR remained reactive, as
expected, and lower than previous measurements at
1:32.
During the patient’s hospitalization, the nephrology
service determined it was prudent to defer renal
biopsy due to the patient’s extenuating physical
and social circumstances, as well as the fact that
the proteinuria was improving while all underlying
causes were being adequately treated.
DISCUSSION
Patients presenting with proteinuria during the
later stages of gestation should receive a thorough
evaluation. The suspicion of preeclampsia should be
foremost. The diagnostic features of preeclampsia
described by the American College of Obstetrics and
Gynecology are as follows: systolic blood pressure
≥140mmHg or diastolic pressure ≥90mmHg on
at least 2 occasions at least 4 hours apart after 20
weeks of gestation in a previously normotensive
patient and the new onset of 1 or more of the
following: proteinuria ≥0.3g in a 24-hour urine
specimen or protein/creatinine ratio of ≥0.3mg/
mmol in random urine specimen or dipstick ≥2+
(if quant is not available); platelet count <100,000/
microL; serum creatinine >1.1mg/dL or doubling
of the creatinine concentration in the absence of
other renal diseases; liver transaminases at least
twice the upper limit of normal concentration;
pulmonary edema; new-onset and persistent
headache not accounted for by alternative diagnosis,
not responding to usual doses of analgesics; visual
symptoms (blurred, flashing lights, scotomata).5 After
the diagnosis of preeclampsia is ruled out, and the
range of proteinuria is greater than accounted for by
physiological changes to the renal filtration system
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during pregnancy, the renal etiology of proteinuria
should be evaluated.
Membranous nephropathy (MN) is the most
common nephrotic syndrome of non-diabetic
patients, particularly in males above the age of
40.6 The incidence of the disease in the general
population is 1.2/100,000 per year, and end-stage
renal disease occurs secondary to membranous
nephropathy in 1.9/million per year.7,8 If present
in women under 40, it is suspicious for secondary
causes such as lupus nephritis. Patients typically
present with proteinuria, hypoalbuminemia, and
hyperlipidemia. Idiopathic forms are associated
with autoantibody against Phospholipase A2, while
secondary causes are most commonly associated
with autoimmune diseases and thyroiditis.
Membranous nephropathy is also known to occur
secondarily to infection (Hepatitis B, Hepatitis C, HIV,
and Syphilis) and NSAIDs, gold, penicillamine, and
captopril use.9 It is associated with malignancy in up
to a third of cases in patients above the age of 60.10
Membranous nephropathy is a rare manifestation
of secondary syphilis (albeit the most common
form of glomerular pathology seen in syphilitic
patients),11 with most reports of syphilitic nephritis
arising from congenital cases of membranous
glomerulonephritis with subepithelial deposits or
intramembranous deposits. Other manifestations
of syphilitic nephropathy include mesangial
proliferative glomerulonephritis, post-infectious
proliferative glomerulonephritis, rapidly progressive
glomerulonephritis with crescents, minimal change
disease, renal gumma, and amyloid renal disease.11
The clinical manifestation of MN is primarily
asymptomatic proteinuria that can range from
sub-nephrotic levels (<3g/day) to 20g/day.12 Severe
hyperlipidemia can be expected in the majority of
cases, but some cases have been reported without
hyperlipidemia.13 Membranous nephropathy is
definitively diagnosed using renal biopsy, which was
not obtained in this case. It can be noted that renal
biopsy is a safe procedure that is not contraindicated
during pregnancy.
Some etiologies of nephrotic syndromes are
reversible, while others are not. Regardless, the
treatment for secondary nephrotic disease is to
treat the underlying etiology along with supportive
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measures. The treatment of primary membranous
nephropathy can be determined using risk
stratification based on immunologic parameters
(PLA2R antibody) and clinical data (creatinine and
eGFR). High or very high-risk patients can be treated
using immunosuppression14; however, some patients
will spontaneously remit.6
The known maternal complications to a mother
due to membranous nephropathy are not welldocumented due to the rarity of this presentation
in pregnancy. However, the clinical complications
of MN most commonly include thrombotic and
thromboembolic events, risk of infection, and
cardiovascular disease. Long-term complications
of nephrotic syndrome consist of progressive loss
of renal function.6 The rate of fetal loss in primary
membranous nephropathy has been documented as
high as 24-35%.15
Nephrotic syndromes manifesting with proteinuria
and hypoalbuminemia have a markedly increased
risk of venous thrombosis.12 Normal pregnancy
adaptations predispose to an increased risk of
coagulation through the acquired resistance
to protein C, a decrease in protein S, and
impaired fibrinolysis.16 Fetal loss associated with
thrombophilia has been reported to be as high as
50%,17 with the hypercoagulable state of pregnancy
causing clot formation in placental vessels and
restricting blood flow to the fetus.18 The combined
effects of nephrotic syndrome and pregnancy
both increasing the risk of thromboembolism can
complicate all stages of pregnancy, particularly at or
shortly after delivery.
Iwakura et al. described membranous nephropathy
in the pregnancy of a 30-year-old female at 26 weeks
gestation with thrombospondin type-1 domaincontaining 7A (THSD7A) in the glomeruli.19 The
diagnosis was made when further evaluation of
her proteinuria was done, and a renal biopsy was
performed, revealing subepithelial deposits in the
glomerular basement membrane. The patient’s 24hour collection of total urine protein was 7.8g/day,
serum albumin was 1.8g/dL, and total cholesterol
was 435mg/dL. Aoshima et al. also described a case
of a 37-year-old female developing MN at 17 weeks
gestation.20 The patient first presented with lower
extremity edema, proteinuria, and microscopic
MARSHALL JOURNAL OF

MEDICINE
™

Expanding Knowledge to Improve Rural Health.

hematuria. Laboratory workup revealed a 24-hour
urinary protein of 2.26g/day, serum albumin of 1.9g/
dL, and total cholesterol of 394mg/dL. Renal biopsy
one week after abortion showed subepithelial and
paramesangial electron-dense deposits. Guillén et
al. described a post-infectious sequala of syphilis
infection in association with Acute IgA dominant
glomerulonephritis in a 16-year-old female
who delivered at 29 weeks, demonstrating that
renovascular disease due to syphilis is not limited to
membranous nephropathy.21 The patient presented
to the hospital due to seizures and unknowingly
being pregnant.
Of interest to this case was a report of a female
patient who also presented with non-gonococcal
chlamydia infection; some forms of glomerular
disease have been associated with bacterial antigens
from chlamydia, such as IgA nephropathy and
mesangiocapillary glomerulonephritis.22 Without
biopsy, these alternative diagnoses cannot be
definitively ruled out. Furthermore, our patient
endorsed the recreational use of methamphetamine.
To our knowledge, there are currently no reports
of membranous nephropathy secondary to
methamphetamine use.
CONCLUSION
Nephrotic syndromes such as membranous
nephropathy should be expeditiously evaluated and
treated during pregnancy. All pregnant patients at
greater than 20 weeks gestation should be evaluated
for preeclampsia, but the differential diagnosis
should not stop there, especially in high-risk patients.
Nephrotic syndromes convey an increased risk for
coagulopathy and other adverse maternal and fetal
outcomes. Membranous nephropathy secondary
to syphilis is rare, but it is becoming increasingly
important to keep it on the differential diagnosis, as
the incidence of syphilis continues to rise. Although
this patient could not be definitively diagnosed with
membranous nephropathy secondary to syphilis
as the kidney biopsy was deferred, the potential
diagnosis was reasonably considered. A high level
of suspicion should be kept for patients at risk of
syphilis infection presenting with proteinuria at
any point during pregnancy, even in high-income
and developed nations. As nephrotic syndromes
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share important diagnostic markers with gestational
pathologies, such as preeclampsia, practitioners
must be aware that syphilis can cause proteinuria.
A missed diagnosis or inappropriate treatment for
proteinuria could lead to serious complications
for the mother and fetus both during and after
pregnancy.
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